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The pyrogenic activity of scarlet fever toxin has been described a number
of times. The "classic" toxin, prepared from the Dochez NY 5 strain, was
found to have a double specificity, designed by Hooker and Follensby as
"A" and "B".1 More recently, Watson has analyzed the antigenic com-
ponents of this toxin and found a third type, which he has denoted "C"1.2
In working with a mutant strain of streptococcus, C 203 U, which pro-
duces streptolysin 0 but not S, the present authors made the observation
that broth culture filtrates of this strain were pyrogenic. An attempt has
been made to determine the relationship of this pyrogen to other strepto-
coccal pyrogens described previously.
MATERIAL AND METHODS
Streptococcus strains: Strains Dochez NY 5 and C 203 U were obtained from the
collections of the Institute of Epidemiology and Microbiology in Prague. Strains T-28,
T-18, and T-19 were kindly supplied by Dr. Watson, University of Minnesota, and
strain 32369 by Dr. Julia Coffey, New York State Department of Health. All these
strains were obtained in the freeze-dried state and were passaged two or three
times in broth before being used.
Medium: Heart Infusion Broth (Difco) was used in part of the work; however,
the medium employed predominantly was one of identical composition but prepared
from beef heart infusion. This contained infusion from 500 g. beef heart (1 litre),
10 g. Tryptose (Difco), and 5 g. sodium chloride. To eliminate extraneous pyrogens
it was autoclaved (1210C.) for two hours and determined to be nonpyrogenic before
use.
The medium was inoculated with the individual strain and incubated for 24 hours.
Supernatant fluid from culture was obtained by ultracentrifugation (Sharples) and
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filtration. It was not further concentrated or purified in order to prevent any com-
ponent of pyrogenicity from disappearing in the purification process.
As a control in some of the experiments, ery*throgenic (scarlet fever) toxin batch
ET 75 or ET 76 prepared from the Dochez NY 5 strain was used; the preparation
and purification of this toxin has been described earlier.'
Enzymes: Three enzymes were used: trypsin 1:250 (Difco), pepsin (Merck), and
papain (Merck).
Rabbits: For the most part, chinchilla rabbits (weighing about 2 kg. each) from
commercial breeds were employed, but some of the experiments were performed with
albino rabbits (weighing about 4 kg.). Injection volumes are expressed in ml/kg.
(chinchilla rabbits) or in ml/animal (albino rabbits). Temperature measurements
were taken by thermoelectric probes* or with an ordinary mercury thermometer,
usually in the course of five hours.
Experimental procedure: Antigenic differences in the pyrogenic substance of the
individual scarlet fever toxins were determined by the method of Watson. Eight or
nine daily intravenous injections of pyrogen elicit a state of so-called pyrogenic
tolerance: the animal has little or no febrile reaction to a further dose of the same
pyrogen, by which is meant that there is either no rise of temperature after the
second hour, or the elevation is within the limit of physiological variation. Watson
has shown that tolerance to the pyrogenic activity of scarlet fever toxin is im-
munologically specific.2 Since tolerance of this type is dependent on the amount of
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FIG. 1. Pyrogenicity of C 203 U filtrate. Abscissa: hours; ordinate: fever in °C.
A: C 203 U filtrate, hml/rabbit e B: C 203 U filtrate, I ml/rabbit these rabbits
died on the day following injection/ C: C 203 U filtrate, 0.3 ml/rabbit.
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FIG..2. Thermostability of pyrogenic effect of C 203 U filtrate. Abscissa : hours;- ordinate: fever in OC. A: filtrate heated 30 min. at 650C., B: filtrate heated 30 min.
at 960C.; all injections i.v., 1 ml/rabbit.
* Foxboro rabbit scanning fever switch and fever recorder. Manufactured by Fox-
boro Co., Foxboro, Mass.
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pyrogen given, it is essential that all pyrogens to be tested be given in approximately
the same fever-inducing dosages.
The curves in the Figures have been drawn on a scale of 1° C. and 1 hour equaling
20 mm. The area under the curve expressed in mm' is the "fever index" (Figs. 1-5).
Resistance to pH change: This was tested at two levels, pH 3 and pH 9. Five
milliliters of filtrate were placed in cellophane tubing and dialyzed overnight against
a corresponding buffer (about 130 ml.) at 4DC. The pH was then checked and ad-
justed back to pH 7.0.
Digestion by proteolytic enzymes: Enzyme was added in a ratio of 1:100 (ca. 40
mg/ml. crude filtrate, 4.5 mg/ml. ET 76, in relation to dry substance). Digestion was
carried out as follows: by trypsin at pH 8.5, pepsin at pH 3.0, and papain (activated
by cysteine) at pH 6.5 at 370C. overnight. The pH was then readjusted to approxi-
mately 7.0. If a precipitate had formed and did not dissolve in adjusting the pH,
it was removed by centrifugation and only the clear supernatant fluid was used for
the injections. The precipitate was checked for its inability to adsorb pyrogenic
activity by resuspending it in a small amount of saline, boiling for a few seconds,
centrifuging it and testing the supernate.
RESULTS
Pyrogenicity of C 203 U filtrate. Doses of 1 ml/rabbit or 0.3 ml/rabbit
were injected intravenously. Temperature measurements were taken by
thermoelectric probes. The results, plotted in Fig. 1, show that the filtrate
was a strong pyrogen. Fever set in after a latent period of almost 1 hour
and had a protracted biphasic course. A dose of 1 ml. was close to the
lethal limit, for two of the five animals receiving it died on the second day.
Nondialyzability of C 203 U pyrogenic factor. Fifteen ml. of filtrate
were dialyzed (Visking, cellophane) against 15 ml. of saline in a re-
frigerator overnight. The dialyzate (saline) was injected into four rabbits.
With one exception, the rabbits were completely afebrile. Hence the pyro-
genic factor did not dialyze.
Thermoresistance of C 203 U pyrogenic factor. Aliquots of filtrate were
heated at either 65° or 960C. in a water bath for 30 minutes. The pre-
cipitate was removed by centrifugation and the clear supernatant fluid
injected in amounts of 1 ml/rabbit. Figure 2 shows that the material re-
tained most of its pyrogenicity even after 30 minutes' exposure to tempera-
tures close to the boiling point. Although the rise in temperature was less
than in Figure 1, it still represents a considerable fever. The paradox of a
lower thermoresistance at 650C. will be discussed below.
This result strongly suggests that the pyrogenic factor belongs to the
"family" of scarlet fever toxins, whose thermoresistance is well known
(at least in the case of the toxin-producing strain Dochez NY 5).4 5
Resistance of pyrogenic factors to pH change. Culture filtrates of strains
T-18, T-19, T-28, and C 203 U were tested. Partly purified scarlet fever
toxin ET 75 (7.5 x 106 STD/ml.) prepared from strain Dochez NY 5
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served as a control. (See METHODS.) The various doses used are given
in the legend to Figure 3, which presents the results.
With all the filtrates, the rise in temperature characteristically began
after a latency of about one hour, and followed a biphasic course with the
second peak occurring relatively late (4-5th hour). Resistance to pH
change was complete with all the filtrates as well as with the control ET
75 toxin, except for filtrate T-28 which showed some loss of activity at
pH 9; difference in temperature from the controls at the fourth and fifth
hour was significant (F-test, 5%o level).
Digestion by proteolytic enzymes. Clear filtrate was injected in doses
indicated in the legend to Figure 4. The temperature rises amounted to
approximately 10C., the peak again occurring in the fourth hour. An excep-
tion was T-28, which was inadvertently given in a slightly smaller dose. The
results are presented in Figure 4. The C 203 filtrate was inactivated by
pepsin only; it was markedly trypsin- and papain-stable. The T-18 and
T-19 filtrates were very similar: they were both papain-resistant but were
digested by pepsin. After treatment with trypsin, T-19 retained a remnant
of its activity, whereas T-18 was digested completely. T-28 was the most
labile toxin of the group. It was inactivated completely by all the enzymes.
The control ET 76 (Dochez NY 5 )toxin was only equivocally affected
by trypsin; pepsin and papain had a considerably greater effect.
These results indicate, first, that all these pyrogens are probably pro-
teins. Their varying susceptibility to the proteolytic enzymes used is evi-
dence of different structure, probably accounted for by differences in the
primary structure of the proteins. It was surprising that trypsin only
slightly affected the ET 76 toxin, whereas T-19 and T-28 were almost
wholly inactivated by this enzyme. By its antigenic structure, the Dochez
NY 5 strain is bivalent AB with a high predominance of A6; strains
T-19 and T-28 are monovalent B and A, respectively. This difference in
susceptibility to trypsin suggests that the two A pyrogens (T-28, Dochez
NY 5) are not completely identical, despite other evidence for their
similarity.
Cross-tolerance tests. The possibility that the C 203 U pyrogen was re-
lated to scarlet fever toxin was investigated in experiments with rabbits
that were made tolerant to the respective pyrogenic substances of T-28,
T-18, T-19, or C-203 U filtrates by daily injections. After developing
tolerance, the rabbits were injected with a filtrate from a different strain.
Since pyrogenic cross-tolerance does not occur when filtrates of unrelated
microorganisms are compared,7 this form of cross-tolerance was considered
to be an argument for the identity of the agents tested in this way. The
cross-tolerance experiments presented here involved all combinations of
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FIGS. 5-7. Cross-tolerance experiments. (Each figure gives one pair of pyrogens.
Left half: temperature values after first dose of tolerance-inducing pyrogen. Tempera-
ture curves of tolerant animals are not given, but the rise never exceeded 0.40C.
Right half: temperature curves after challenge administered on the day after toler-
ance had been attained. Figures in brackets denote numbers of animals in experiment.)
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C 203 U with monovalent filtrates T-18, T-19, and T-28. In addition, it
was considered expedient to verify the identity of strains T-19 and 32369
by cross-tolerance tests. The T-19 strain produces a pyrogen that has
been designated by Watson as B on the assumption that it was scarlet
fever toxin.2 The 32369 strain also is said to produce scarlet fever toxin
B.8 However, a direct comparison of both strains had not previously been
performed. The results are plotted in Figures 5, 6, 7 and 8, where the
technical details are also given. From the evidence in these cross-tolerance
tests, the two strains, T-19 and 32369, appear to produce an identical
pyrogen (see Fig. 8).
The only other instance of cross-tolerance was observed with C 203 U
(induction of tolerance) and T-18 (challenge); the same system in the
reverse order, however, did not produce cross-tolerance (Fig. 5).
Watson's strains have their respective pyrogenic (erythrogenic) activi-
ties denoted as follows: T-28 as A, T-19 as B, and T-18 as C. Our findings
indicate that the C 203 U strain produces the pyrogenic component C and
another pyrogen that appears to be distinct from the previously known
types and has, therefore, been denoted D. A corresponding monovalent
strain producing pyrogen D only has not been described. On the basis of
these data, the pyrogenic structure of strain C 203 U has been designated
as CD.
DISCUSSION
In this study an attempt has been made to determine the character of
the C 203 U strain pyrogen. In doing so it was necessary to establish
some of the basic characteristics of scarlet fever toxins other than the
"classic" Dochez NY 5 toxin.
4t Toierance Challenge
1.0 T-to 0,2rM/ko { () 32369 OJ m/kg
32369 01mI/kg (6) T-19
1 2 3 4 5 I 2 3 4 A
Hours
FIG. 8. Cross-tolerance between T-19 and 32369 pyrogens. (Arrangement as in
Figures 5-7.)
38
Volume 43, August, 1970r SCHUH, HRIBALOVA, ATKINS
With the use of the skin test as an indicator system for in vitro mixtures
of toxin-antitoxin, it has been suspected for some time that scarlet fever
toxins are serologically heterogeneous.8'8'9 Coffey, whose work is the most
extensive on this subject, suggests the existence of both single types and
combinations.8 The Dochez NY 5 toxin appears to have at least two
specificities. This point was investigated by Hooker and Follensby, who
designated the predominant component of the toxic filtrate of this strain
as A and a second, minor component as B." Like Coffey, they also found
strains that produced toxin B only. The exact number of antigenic types
of scarlet fever toxin has not yet been conclusively ascertained. Wheeler
has published a table from which at least five antigenic variants (single
or combinations) can be inferred, with strain Dochez NY 5 figuring as
trivalent.9 Coffey, working in the same institute, analyzed 597 strains six
years later, with results also suggesting the existence of five variants and
a bivalent status for the Dochez NY 5 strain.8 In both cases, these are
deductions from the data, since the authors themselves do not specify the
number of antigenic variants.
These authors based their antigenic studies solely on the results of
skin tests, since dermal activity was the only biological test for scarlet
fever toxin known at that time. More recently, Watson has attempted to
differentiate scarlet fever toxins on the basis of cross-tolerance to their
pyrogenic action, which, like the results of skin tests, appear to indicate
that these agents are immunologically specific.2 He also found the Dochez
NY 5 strain to be bivalent. He found a strain (T-28) that produced toxin
A only, and another (T-19), producing only toxin B, and a third (T-18)
producing toxin C. The respective letters need not, of course, signify
single antigens but may represent groups of antigens, none of which is
present in any of the other designations. Strain T-19 was identified as a
toxin producer by Watson only in relation to the known bivalent Dochez
NY 5 toxin.
Utilizing the technique of cross-tolerance, we have confirmed here that
Watson's T-19 strain and the 32369 strain, a producer of toxin B,8,10
produce an identical pyrogen.
Strain C 203 U appears to be a further strain (in addition to Dochez
NY 5) which is at least bivalent; it possesses the pyrogenic component
C (identical with strain T-18), but also a further one, distinct from Wat-
son's A and B. Hence, it has here been designated as D, the symbol being
assigned the same meaning as has been reserved for the letters A to C.
Since scarlet fever toxin heterogeneity has been demonstrated by two
different methods-the skin test and pyrogenicity-and a correlation be-
tween these two activities has been shown in strain Dochez NY 5 only,
39
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one may ask what evidence permits us to group all these substances as
scarlet fever toxins. Apart from clinical experience, the assumption is
based on the observations that these "toxins" are produced by streptococci
isolated from scarlet fever cases, that they elicit an erythema after intra-
dermal injection, and are neutralized by their respective antisera. Actually,
only the Dochez NY toxin, or more precisely, toxin A, has been proved
to be a scarlet fever toxin. It has been found to fulfil the so-called Koch
criteria and has been purifiedl"' and its pyrogenicity has been demon-
strated.2 With toxin B, which has not been satisfactorily purified, our
certainty is somewhat weaker, while the information relating to toxin C
and the pyrogenic compenent D is very scanty.
The pyrogenic activity of streptococcus C 203 U filtrate has a potent
pyrogenic activity. Intravenous doses of 1 ml/rabbit were lethal to two
of the five rabbits: a dose of 0.3 ml. elicited a rise in temperature of more
than 1.5°C. Despite this, the latency period was relatively long, longer
than with endotoxin (see Fig. 1).
The relatively long latency before onset of fever seen with the pyrogens
studied here deserves some attention. A similar phenomenon has been
previously noted after administration of T-18 strain toxin by Watson and
Kim.'3 The present authors encountered this finding with all exogenous
streptococcal pyrogens, including partly purified scarlet fever toxins and
crude filtrates. Although this finding might also suggest that the substances
are related and differ from the endotoxins of gram-negative bacteria,'4
culture filtrates of other microorganisms (staphylococci and tubercle bacilli
as well as certain pathogenic fungi) produce biphasic fevers with a similarly
delayed onset in either naturally or specifically sensitized rabbits.'1 Fur-
ther experiments, utilizing the pyrogenic cross-tolerance techniques em-
ployed here should give useful information as to possible antigens shared
in common between these diverse groups of microorganisms. Earlier work
has indicated that the pyrogens in culture filtrates of tubercle bacilli (old
tuberculin) and certain strains of coagulase positive staphylococci are
distinct.7
The pyrogenicity of C 203 U filtrate is highly thermoresistant. It is
still well retained after heating at nearly the boiling point (96°C.) for 30
minutes. Such thermoresistance has been observed in a partially purified
scarlet fever toxin with proved pyrogenicity.4'5 The paradoxical result
obtained in the filtrate heated to only 65°C. is explicable by some previous
findings. In earlier work with crude scarlet fever toxin (Dochez NY 5),
the thermoresistance of the toxin was tested by skin tests. On heating
the toxic filtrate to 65°C., a flaky precipitate appeared and it was found
that the dermal activity of the supernatant fluid decreased. The flakes
40
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resuspended in saline and boiled for a short interval liberated a toxin that
had skin activity and that apparently had only been absorbed on the flakes
(Schuh and Splitkova, unpublished results). A similar phenomenon has
been described in older reports concerning the thermoresistance of staphy-
lococcal alphatoxin.18
Resistance to extreme pH values is a known characteristic of scarlet
fever toxin. This applies to the Dochez NY 5 toxin, for which pH resis-
tance in the range of pH 1.08 to > 11.0 has been reported."' It follows
from the present results that the other streptococcal pyrogens (toxins)
behave similarly. Only in the case of the T-28 strain was the pyrogen partly
inactivated in the alkaline pH range.
The susceptibility of scarlet fever toxin to proteolytic enzymes has been
studied in toxin Dochez NY 5 (components AB) and toxin B.""'0
The method employed was not always the same and in some cases it has
not been adequately described. In most cases the criterion was skin activity;
Hottle and Pappenheimer determined toxin activity by flocculation.21
They found erythrogenic toxin (Dochez NY 5) to be resistant to trypsin,
pepsin, and papain. In the present work, where the criterion of toxin
activity was pyrogenicity, digestion with trypsin left pyrogen Dochez NY
5 activity almost completely unimpaired. In view of the results of other
authors, the question arises whether skin activity of this toxin would like-
wise be preserved under the present experimental conditions. Pepsin and
papain inhibited pyrogenic activity to a far greater degree. The C 203
U pyrogen also proved to be trypsin-resistant. Both these strains, i.e.,
Dochez NY 5 and C 203 U, possess antigenically mixed pyrogens, viz.,
AB and CD, respectively. It is of interest that "univalent" pyrogens A,
B, and C were easily digested by trypsin. Whether trypsin-resistance is
significantly related to bivalence or is merely coincidental cannot be stated
at present. Toxin B has been reported by others to be easily digestible by
trypsin.6,10
The pyrogens presented here have been classed together on the basis
of certain properties (thermoresistance, pH resistance, character of pyro-
genic response) that no other streptococcal product possesses. Further
evidence in addition to their pyrogenicity will be necessary, however, before
these substances can be unequivocally classified as scarlet fever toxins.
SUMMARY
Various biological properties of the pyrogens belonging to the so-called
"scarlet fever" group of streptococcal toxins were investigated. By their
thermoresistance, pH resistance and the febrile response they induce, these
agents appear to resemble each other and to be separable from other strep-
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tococcal products. On the basis of fever studies, there appear to be at
least four separate pyrogenic agents, each representing a different antigenic
component. A new pyrogen, tentatively designated as "D," has been found
in culture filtrates of a mutant strain of streptococcus (C203U). Its rela-
tionship to three previously described streptococcal pyrogens has been
defined.
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